Abstract
Radiotherapy is still one of the most effective nonsurgical treatments for many tumors. However, radioresistance remains a major impediment to radiotherapy. Although COX-2 inhibitors can induce radiosensitization, the underlying mechanism is not fully understood. In this study, we showed that COX-2 selective inhibitor celecoxib enhanced the radiation-induced inhibition of cell proliferation and apoptosis in HeLa and SACC-83 cells. Treatment with celecoxib alone dephosphorylated phosphatase and tensin homolog deleted on chromosome ten (PTEN), promoted PTEN membrane translocation or activation, and correspondingly dephosphorylated or inactivated protein kinase B (AKT). By contrast, treatment with radiation alone increased PTEN phosphorylation, inhibited PTEN membrane translocation and correspondingly activated AKT in the two cell lines. However, treatment with celecoxib or another COX-2 selective inhibitor (valdecoxib) completely blocked radiation-induced increase of PTEN phosphorylation, rescued radiation-induced decrease in PTEN membrane translocation, and correspondingly inactivated AKT. Moreover, celecoxib could also upregulate PTEN protein expression by downregulating Sp1 expression, thereby leading to the activation of PTEN...Continue Reading
References
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·L C Cantley, B G Neel
Feb 5, 2000·Biochimica Et Biophysica Acta·F Vazquez, W R Sellers
Jun 24, 2000·Molecular and Cellular Biology·F VazquezW R Sellers
Oct 18, 2000·The Journal of Biological Chemistry·J Torres, R Pulido
Mar 29, 2001·Radiology·L W BradyW E Powers
Jun 29, 2002·Circulation Research·Ichiro Shiojima, Kenneth Walsh
Sep 26, 2002·FEBS Letters·Susan J MillerBenjamin G Neel
Feb 26, 2003·Radiation Research·Paul DentRupert Schmidt-Ullrich
Aug 30, 2003·Oncogene·Kristoffer Valerie, Lawrence F Povirk
Jan 9, 2004·The Biochemical Journal·Steven M WalkerC Peter Downes
May 4, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhongxing LiaoJames D Cox
May 11, 2005·Molecular Pharmacology·Maen Abdelrahim, Stephen Safe
Jul 12, 2005·Oncogene·Soo-Jin JeongJohn N Brady
Aug 25, 2005·Gut·D Wang, R N Dubois
Jan 10, 2006·Seminars in Oncology·Luka MilasJaffer Ajani
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Francisca VazquezPeter N Devreotes
Jan 11, 2007·Oncogene·G DenningP K Vogt
Nov 6, 2007·Current Cancer Drug Targets·Xinhai ZhangChuanshu Huang
Mar 1, 2008·The Lancet Oncology·Johan BussinkJohannes H A M Kaanders
Jul 16, 2008·Oral Oncology·Kai HuGuang-Yan Yu
Sep 5, 2008·Annual Review of Pathology·Nader Chalhoub, Suzanne J Baker
Nov 26, 2008·Seminars in Radiation Oncology·Jacques Bernier
Apr 3, 2009·Inflammopharmacology·R E Harris
Mar 5, 2010·Clinical Lung Cancer·Mariano ProvencioFrancisco Valcárcel
Jun 8, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Kuan-Hsuan ChenYi-Wei Chen
Nov 3, 2011·Future Oncology·Santosh KesariClark C Chen
Jun 12, 2012·Free Radical Biology & Medicine·Saelooom LeeJie-Young Song
Oct 30, 2012·Carcinogenesis·Xiao-Xing KouYe-Hua Gan
Dec 3, 2014·The International Journal of Biochemistry & Cell Biology·Kamal DattaAlbert J Fornace
Citations
Jun 27, 2017·Anti-cancer Drugs·Xia ChenJufang Huang
Sep 22, 2019·Cells·Wanyeon KimBuHyun Youn
Aug 22, 2018·Oncology Letters·Ruijun LiuQingquan Luo
Nov 24, 2016·Oncology Reports·Lingfei JiaYehua Gan
Aug 10, 2017·Oncology Reports·Dao-Ying YuanBin Zhang
Mar 9, 2019·Journal of Bioenergetics and Biomembranes·Seyed Jalal HosseinimehrHossein Asgarian-Omran
Oct 20, 2017·Oncology Reports·Guanhua Zhang, Ye-Hua Gan
Jul 5, 2018·Cancer Metastasis Reviews·Wanyeon KimBuHyun Youn
Nov 10, 2020·International Journal of Radiation Biology·Pan ZhangYang Song
Dec 15, 2020·Critical Reviews in Oncology/hematology·Chiman MohammadiRezvan Najafi
Jan 26, 2021·Toxicological Research·Seung Mi ChoiKyung-Soo Chun
Dec 6, 2016·European Journal of Pharmacology·Ping XuDan-Dan Lu
Aug 17, 2021·Frontiers in Oncology·Peng LiJinchang Wu